Alan K. Burnett

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

Mark A. Dawson, Rab K. Prinjha, Antje Dittmann et al. · Nature · 2011 · 1.5K citations · Full text

Life Sciences, Hematology, Molecular Biology +10

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

Anthony H. Goldstone, Alan K. Burnett, Keith Wheatley et al. · Blood · 2001 · 437 citations

Medicine, Hematology, Oncology +14

FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia

Adam J. Mead, David C. Linch, Robert K. Hills et al. · Blood · 2007 · 323 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

The prognostic significance of IDH2 mutations in AML depends on the location of the mutation

Claire L. Green, C. M. Evans, Lu Zhao et al. · Blood · 2011 · 267 citations · Full text

Medicine, Genetics, Molecular Genetics +10

Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signaling

Paul S. Hole, Joanna Zabkiewicz, Chinmay Munje et al. · Blood · 2013 · 230 citations

Life Sciences, Cancer Biology, Molecular Biology +15